Oncogenetic testing makes it possible to identify hereditary mutations in genes associated with different types of cancer. This information is key for prevention, as it allows for early decisions regarding medical follow-up, lifestyle changes, or even preventive interventions in individuals at high genetic risk.

In addition to hereditary cancer, oncogenetics is also applied in the study of already diagnosed tumors, as it helps personalize treatments according to the patient’s genetic profile. Thanks to these advances, the clinical laboratory has become a key ally in early detection, personalized treatment, and follow-up of cancer patients, with the aim of increasing their chances of recovery.